Sun Pharma Ltd. has declared the results of Q2 FY16

Company has posted not good results. On the consolidated basis, for the current quarter ended September 30, 2015 company has reported 41.1% decline & 14.7% rise in net profit and 46% decline & 11.5% rise (ex. Exceptional items) in Profit after tax as compared to for the same quarter in the previous year ended September 30, 2014 and for previous quarter ended June 30, 2015. Net Revenues of the company has decreased by 14.7% on Y-O-y basis and increased marginally by 4.3% on Q-o-Q basis.

Company had incurred exceptional losses of 685 cr. in previous quarter ended June 30, 2015. Exceptional expenses are not ordinary expenses and occur rarely and have no impact in future earnings. So we have filtered those effects. Latest Key Indicators of the stock are as follows:

Key Market Indicators (Consolidated)
Latest Date 06-Nov-2015
Latest Price (Rs) 803.70
Previous Close (Rs) 815.85
1 Day Price Var% -1.49
1 Year Price Var% -9.86
52 Week High (Rs) 1200.70
52 Week Low (Rs) 798.80
Beta 0.80
Face Value (Rs) 1.00
Industry PE 31.66
TTM Period 201509
TTM EPS(Rs) 16.20
TTM CEPS(Rs) 25.55
Price/TTM CEPS(x) 31.46
TTM PE (x) 49.61
Price/BV(x) 7.36
EV/TTM EBIDTA(x) 26.04
EV/TTM Sales(x) 8.06
Dividend Yield% 0.37
MCap/TTM Sales(x) 8.14
Latest Book Value (Rs) 109.25
Market Cap (Rs. In Crores) 193413.30
EV (Rs. In Crores) 191411.37
Latest no. of shares (In Crores) 240.65

Comparison of quarterly results with previous quarter (Q-o-Q) and the same quarter of last year (Y-o-Y) is below:

DESCRIPTION Sep-15 Sep-14 Var% Jun-15 Var%
Net Sales 6,803 7,979 -14.7 6,522 4.3
Other operating income 34 60 -42.9 235 -85.4
Net Sales & Other Operating Income 6,837.61 8,039.37 -14.95 6,757.58 1.2
Total Expenditure 4,904 4,973 -1.4 4,908 -0.1
PBIDT (Excl OI) 1,934 3,066 -36.9 1,850 4.5
Other Income 191 -31 718.6 105 81.6
Operating Profit 2,125 3,035 -30.0 1,955 8.7
Interest 148 162 -8.2 123 20.7
Exceptional Items       -685  
PBDT 1,977 2,874 -31.2 1,147 72.3
Depreciation 271 269 0.8 240 12.9
PBT 1,705 2,605 -34.5 907 88.1
Tax 335 279 20.1 227 47.9
Profit After Tax 1,370 2,325 -41.1 680 101.5
           
Profit After Tax (Excluding Exceptional Items) 1,370 2,325 -41.1 1,194 14.7
           
Minority Interest -270 -274 1.4 -201 34.7
Shares of Associates 7 -1 1038.7 0  
Consolidated Net Profit 1,107 2,050 -46.0 479 131.1
           
Net Profit (Excluding Exceptional Items) 1,107 2,050 -46.0 993 11.5
           
Adj. EPS 4.60 9.90 -53.5 1.99 131.2
           
Adj. EPS (Excluding Exceptional Items) 4.60 9.90 -53.5 4.13 11.5
           
PBIDTM% (Excl OI) 28.3 38.1 -25.9 27.4 3.3
PBIDTM% 31.1 37.8 -17.7 28.9 7.4
PBDTM% 28.9 35.7 -19.1 17.0 70.4
PBTM% 24.9 32.4 -23.0 13.4 85.8
PATM% 20.0 28.9 -30.7 10.1 99.2
           
PATM% (Excluding Exceptional Items) 20.04 28.92 -30.7 17.67 13.4
Tagged with: , , , , , , , , , , ,
Posted in Global News, Indian Market, Market Updates, Useful Articles